Biopharma News
Sage Therapeutics to Implement a 40% Workforce Reduction
Sage Therapeutics, Inc announced late last week plans to reorganise its business operations and pipeline priorities to support goals for long-term business growth. Read more
4 Sep 2023
IO Biotech Appoints Heidi Hunter to its Board of Directors
IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win technology platform, announced the appointment of Heidi Hunter to its board of directors. Read more
11 Aug 2023
Lytix Biopharma’s Licensing Partner Verrica Pharmaceuticals Reports Interim Phase 2 Data With LTX-315
Lytix Biopharma announces that its licensing partner Verrica Pharmaceuticals Inc has reported lesion clearance data from Part 1 of an ongoing Phase 2 study of VP-315 (formerly known as LTX 315) for the treatment of basal cell carcinoma (BCC). Read more
11 Aug 2023
Kincell Bio Launches with $36M to Make Cell Therapy Development and Manufacturing Accessible for Early-Stage Innovators
Kincell Bio, a technology-forward contract development and manufacturing organisation (CDMO) focused on cell therapies, emerged from stealth with $36 million in new funding. Read more
7 Aug 2023
AstraZeneca appoints Sharon Barr as Executive Vice President BioPharmaceuticals R&D
AstraZeneca today announced the appointment of Sharon Barr as Executive Vice President, BioPharmaceuticals R&D. Read more
4 Aug 2023
Trelleborg Launches BioPharmaPro Range
Trelleborg Healthcare and Medical launches the BioPharmaPro family of innovative products, materials and services for fluid path single-use equipment to accelerate the advancement of life-changing therapies. Read more
28 Jul 2023
Leqembi, Donanemab and Tofersen: The End of the Journey or the First Step on the Road to Reversing Neurodegeneration?
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem. Read more
16 Aug 2023
R&D revolution: A new paradigm of sourcing and landscaping for the pharma industry
Dr Robin Knight, Co-Founder & Co-CEO of IN-PART, discusses the emerging importance of outsourcing landscaping activities within the pharmaceuticals industry and the benefits of adopting an openly innovative approach that pools sources of innovation. Read more
12 Jul 2023
Enhancing Biotherapeutic Properties with Cell-Line Engineering
Neha Mishra, Ph.D, Senior Scientist Bioproduction at Revvity explores enhancing biotherapeutic properties with cell-line engineering. Read more
30 Jun 2023
CPHI Roundtable: Tjoapack
As we look back on this year's CPHI Barcelona show, we put together a collection of thoughts from some of the industry's leading voices. In our second feature, we speak to Marcelo Cruz, VP Business Development & Marketing at Tjoapack. Read more
30 Nov 2023
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Bormioli and Desall Digitise Package Leaflets Using Augmented Reality
Bormioli Pharma has announced that it has chosen the winner of the open innovation competition launched on the Desall.com platform for the creation of innovative pharmaceutical packaging prototypes. Read more
30 Nov 2023
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Hovione Expands Nasal Drug Delivery in Collaboration with IDC
Hovione has announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC. Read more
30 Nov 2023
CPHI Roundtable: Purolite
As we look back on this year's CPHI Barcelona show, we put together a collection of thoughts from some of the industry's leading voices. To kick things off, we speak to Felix Solamo, Senior Global Director, Field Applications Scientist at Purolite. Read more
29 Nov 2023
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Shutterstock
Orphelia Pharma Secures US Patent
Orphelia Pharma have announced that the US Patent and Trademark Office (USPTO) has issued patent US11/730,732 for KIZFIZO, the first pediatric and ready-to-use drinkable formulation of temozolomide. Read more
29 Nov 2023
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Shutterstock
PlaqueTec Recruits First Ten Patients in BIOPATTERN Trial
PlaqueTec have announced that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD. Read more
29 Nov 2023
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15